Article
Lymphangioleiomyomatosis: pathogenesis, clinical features, diagnosis, and management.
The Lancet. Respiratory medicine - 1 Nov 2021
McCarthy Cormac, Gupta Nishant, Johnson Simon R, Yu Jane J, McCormack Francis X
Abstract excerpt
Lymphangioleiomyomatosis (LAM) is a slowly progressive, low-grade, metastasising neoplasm of women, characterised by infiltration of the lung parenchyma with abnormal smooth muscle-like cells, resulting in cystic lung destruction. The invading cell in LAM arises from an unknown source and harbours mutations in tuberous sclerosis complex (TSC) genes that result in constitutive activation of the mechanistic target...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
